The global neurostimulation device market is expected to grow to nearly $4.1 billion by 2018, according to a recently released report by BCC Research.
The market is expected to grow at a five-year compound annual growth rate of 1.5 percent.
The largest segment in the overall market is the chronic pain category, which is projected to reach $2.8 billion by 2018.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws